Rice Bran Arabinoxylan Compound Drug Interactions

Every one of the 2,830 drugs in our catalog, checked against Rice Bran Arabinoxylan Compound and graded by severity from the Natural Medicines database. Open any drug for its full report: the mechanism, how likely it is, the evidence and the studies.

Dr. Brian Staiger, PharmD, BCPS
This page is medically reviewed by
Updated October 2026 · How this page is built

2,830 Drugs Checked

121 have a documented interaction with Rice Bran Arabinoxylan Compound. None is rated major.

  1. Major None found
  2. Moderate 1214%
  3. Minor None found
  4. No known interaction 2,70996%

Each bar is that group’s share of all 2,830 drugs. Select one to see those drugs in the list.

What to Watch For With Rice Bran Arabinoxylan Compound

From the HelloPharmacist Editorial Team · Updated July 2026

Based on the available evidence, the overall risk of a clinically significant Rice Bran Arabinoxylan Compound drug interaction appears low for most people, though those taking medicines that suppress the immune system are the exception.

None of the listed interactions are rated major, and every one traces back to a single theoretical concern involving one class of medications.

Interactions Deserving the Most Attention

  • The interactions that matter most involve immunosuppressants, such as cyclosporine, azathioprine, and similar transplant or autoimmune medicines.
  • Rice bran arabinoxylan compound has been shown in lab and human research to stimulate immune cell activity, so in theory it could work against drugs that are meant to calm the immune system.
  • Because transplant medicines have a narrow margin for error, even a theoretical effect deserves caution in this group.

What the Rest of the List Means

  • Although the list of interacting medications looks long, it reflects one shared concern spread across the many drugs in this single class, not dozens of separate problems.
  • The interaction is graded as theoretical, meaning it is based on the supplement's known immune-stimulating activity rather than documented harm in people taking these medicines together.

The Kinds of Drugs Rice Bran Arabinoxylan Compound Affects

Every drug category Rice Bran Arabinoxylan Compound is known to interact with, as the Natural Medicines database names and describes them, most serious first, each with everyday drugs from our list. Open any category for the mechanism, how likely it is and the evidence grade.

Find your drug’s categoryType a drug you take to see which kind of drug it is and whether Rice Bran Arabinoxylan Compound affects it.

Immunosuppressants Moderate 121 drugs on our list, including Tacrolimus (Prograf (capsule)), Prednisone (Deltasone), Dexamethasone (Decadron)

Theoretically, rice bran arabinoxylan compound might interfere with immunosuppressants by stimulating the immune system. In laboratory and human research, rice bran arabinoxylan compound has been shown to stimulate the activity of immune cells.
Some immunosuppressants include azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, Prograf), sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids), and others.

How likely Possible Evidence grade D

The 8 studies behind this: 12345678

See the moderate drugs on the list below

Every Drug, Graded

All 2,830 drugs we checked against Rice Bran Arabinoxylan Compound, each linking to its own page with the full detail. Every one is on this page; the filters only change what is shown.

Find your drug Search by generic or brand name, or show one severity at a time.

2,830 drugs
Moderate: 6-mercaptopurinePurinethol Moderate: AbrocitinibCibinqo Moderate: AdalimumabHumira Moderate: Adalimumab-adazHyrimoz Moderate: Adalimumab-adbmCyltezo Moderate: Adalimumab-afzbAbrilada Moderate: Adalimumab-attoAmjevita Moderate: Adalimumab-bwwdHadlima Moderate: Adalimumab-fkjpHulio Moderate: AlefaceptAmevive Moderate: AlemtuzumabCampath Moderate: Anifrolumab-fniaSaphnelo Moderate: Antithymocyte GlobulinThymoglobulin Moderate: AtezolizumabTecentriq Moderate: AzamuneImmunoprin Moderate: AzathioprineAzamune, Imuran Moderate: BasiliximabSimulect Moderate: Beclometasone DipropionateBecotide Moderate: BeclomethasoneBeclovent, Vanceril Moderate: Beclomethasone DipropionateQNASL, Qvar Moderate: BetamethasoneCelestone, Diprolene AF, Diprosone Moderate: Betamethasone DipropionateSernivo Moderate: Betamethasone Dipropionate, CalcipotrieneEnstilar, Wynzora Moderate: Betamethasone ValerateLuxiq Moderate: Bimekizumab-bkzxBimzelx Moderate: CiclesonideAlvesco, Omnaris, Zetonna Moderate: CisplatinPlatinol-AQ Moderate: CladribineLeustatin, Mavenclad Moderate: CopanlisibAliqopa Moderate: Cortisone AcetateCortisone Tablets, Cortone

What Severity, Likelihood and Evidence Mean

Severity: How Serious It Can Be

  • Major. Clinically significant; generally best avoided, or used only under direct professional supervision.
  • Moderate. May need monitoring, a dose adjustment, or separating the times you take each one.
  • Minor. Generally not clinically significant, but still worth noting and mentioning to your pharmacist.
  • No known interaction. Checked against our sources with nothing documented. That is not the same as proven safety.

Likelihood: How Well It’s Documented

  • Likely. Well-controlled human studies have demonstrated the likely existence of this interaction.
  • Probable. Interaction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
  • Possible. Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.
  • Unlikely. Interaction has been demonstrated in animal or in lab research but has been shown not to occur in humans.

Where This Data Comes From

  • Interaction records are evidence-graded and sourced from the Natural Medicines database (TRC Healthcare), the same reference used by pharmacists and hospitals.
  • Each drug listed above links to the full report for that exact Rice Bran Arabinoxylan Compound combination: clinical detail, likelihood, evidence level, and citations.
  • Content is reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards.

The 8 References Behind These Interactions

Every study and source the Natural Medicines database cites for Rice Bran Arabinoxylan Compound’s drug interactions, with a PubMed or DOI link where we could verify one. The numbers match the ones under each kind of drug above.

  1. Ghoneum M, Namatalia G, Kim C. Effect of MGN-3 on human natural killer cell activity and interferon-y synthesis in vitro. FASEB 1996;10:26-32.
  2. Ghoneum M, Jewett A. Synergistic effect of modified arabinoxylane (MGN-3) and low dose of recombinant IL-2 on human NK cell activity and TNF-a production. American Academy of Anti-Aging Medicine, Education Conference 1998.
  3. Salama H, Medhat E, Shaheen M, Zekri AN, Darwish T, Ghoneum M. Arabinoxylan rice bran (Biobran) suppresses the viremia level in patients with chronic HCV infection: A randomized trial. Int J Immunopathol Pharmacol. 2016;29(4):647-653. PubMed
  4. Ghoneum M, Agrawal S. Mgn-3/biobran enhances generation of cytotoxic CD8+ T cells via upregulation of dec-205 expression on dendritic cells. Int J Immunopathol Pharmacol. 2014;27(4):523-30. PubMed
  5. Cholujova D, Jakubikova J, Czako B, et al. MGN-3 arabinoxylan rice bran modulates innate immunity in multiple myeloma patients. Cancer Immunol Immunother. 2013;62(3):437-45. PubMed
  6. Ghoneum M, Agrawal S. Activation of human monocyte-derived dendritic cells in vitro by the biological response modifier arabinoxylan rice bran (MGN-3/Biobran). Int J Immunopathol Pharmacol. 2011;24(4):941-8.
  7. Ghoneum M, Matsuura M. Augmentation of macrophage phagocytosis by modified arabinoxylan rice bran (MGN-3/biobran). Int J Immunopathol Pharmacol. 2004;17(3):283-92. PubMed
  8. Ghoneum M, Jewett A. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro. Cancer Detect Prev. 2000;24(4):314-2

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC